Geisinger Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Geisinger |
Case, Control |
548 |
10,331 |
|
|
KPWHIR Anxiety Implementation |
Anxiety algorithm |
KPWHRI |
Case, Control |
536 |
516 |
|
|
GH/UW Verification |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Group Health and University of Washington |
Case, Control |
479 |
319 |
100%, 100% |
100%, 100% |
Harvard_NAFLD_Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
|
Case, Control |
453 |
9,273 |
|
|
Vanderbilt Migraine Implementation |
Migraine |
Vanderbilt |
Case, Control |
433 |
10,077 |
|
|
Severe Early Childhood Obesity - CCHMC |
Severe Early Childhood Obesity |
Cincinnati Children's Hospital Medical Center |
Case Only |
428 |
|
90% |
72% |
KPWHRI implementation Autoimmune Disease Phenotype |
Autoimmune Disease Phenotype |
KPWHRI |
Case, Control |
419 |
614 |
|
|
Venous Thromboembolism Implementation - Columbia |
Venous Thromboembolism (VTE) |
Columbia University |
Case, Control |
419 |
2,574 |
|
|
Mayo Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
416 |
278 |
|
|
Cardiac Conduction (QRS) Implementation - Columbia |
Cardiac Conduction (QRS) |
Columbia University |
Case Only |
396 |
|
|
|
NAFLD KPWA |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
KPWA/UW |
Case, Control |
383 |
5,236 |
|
|
Mayo Clinic Anxiety Implementation |
Anxiety algorithm |
Mayo Clinic |
Case, Control |
367 |
546 |
|
|
Demographics and HxDiseasDx Data Files |
Migraine |
KPWHRI |
Case, Control |
362 |
2,146 |
|
|
demog and HxDiseasDx data |
Migraine |
KPWHRI |
Case, Control |
362 |
2,146 |
|
|
Geisinger Implementation |
Rheumatoid Arthritis (RA) |
Geisinger |
Case, Control |
351 |
12,402 |
|
|
Geisinger Implementation |
Hearing Loss |
Geisinger |
Case, Control |
336 |
6,479 |
|
|
NU Validation and Results |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Northwestern University Feinberg School of Medicine |
Case, Control |
334 |
720 |
98%, 92% |
92%, 98% |
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
T2DM Implementation - Columbia |
Type 2 Diabetes Mellitus |
Columbia University |
Case, Control |
293 |
478 |
|
|
CCHMC - AID Phenotype |
Autoimmune Disease Phenotype |
|
Case, Control |
277 |
452 |
|
|
KPWA UW CRS |
CRS (Chronic Rhinosinusitis) |
|
Case, Control |
272 |
953 |
|
|
Vanderbilt Implementation of caMRSA |
caMRSA |
Vanderbilt University |
Case, Control |
262 |
2,313 |
|
|
Resistant hypertension Implementation - Columbia |
Resistant hypertension |
Columbia University |
Case, Control |
249 |
1,031 |
|
|
Geisinger Imp |
CRS (Chronic Rhinosinusitis) |
Geisinger |
Case, Control |
221 |
2,648 |
|
|
Harvard Implementation |
Statins and MACE |
Partners Healthcare |
Case, Control |
214 |
1,113 |
|
|